ALZN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Alzamend Neuro's Phase 1/2A lithium imaging data were accepted for an oral presentation at the ISMRM X-Nuclei MR workshop in BarcelonaAug 18, 2026
- Alzamend reported encouraging pharmacodynamic data from Phase 2 AL001 studyApr 7, 2026
- Alzamend reported positive Phase 2 results for AL001 showing enhanced brain delivery of lithiumMar 26, 2026
- Alzamend Neuro announced completion of clinical portion of Phase II trial of AL001 'Lithium in Brain' study conducted at Massachusetts General HospitalNov 19, 2025
- Alzamend Neuro starts dosing first patient in Phase II 'Lithium in Brain' study at Massachusetts General HospitalMay 29, 2025